GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
+11.04%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$3.06B
AUM Growth
+$135M
(+4.6%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
31.12%
Holding
185
New
13
Increased
101
Reduced
62
Closed
9
Top Buys
| 1 |
HubSpot
HUBS
|
$41.6M |
| 2 |
indie Semiconductor
INDI
|
$33.1M |
| 3 |
Toast
TOST
|
$21.8M |
| 4 |
First Solar
FSLR
|
$21.1M |
| 5 |
Globant
GLOB
|
$17.8M |
Top Sells
| 1 |
Enphase Energy
ENPH
|
$56M |
| 2 |
Array Technologies
ARRY
|
$37.1M |
| 3 |
OSI Systems
OSIS
|
$28.9M |
| 4 |
Bright Horizons
BFAM
|
$27.1M |
| 5 |
Evolent Health
EVH
|
$25.4M |
Sector Composition
| 1 | Technology | 41.81% |
| 2 | Healthcare | 19.02% |
| 3 | Industrials | 14.36% |
| 4 | Consumer Discretionary | 8.97% |
| 5 | Communication Services | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
CorVel
CRVL
$4.41B
| $5.26M | 0.17% |
113,877
+28,644
| +34% | +$1.32M |
|
127
Mesa Laboratories
MLAB
$354M
| $4.91M | 0.16% |
34,895
-31,955
| -48% | -$4.5M |
|
128
Green Brick Partners
GRBK
$3.14B
| $4.79M | 0.16% |
223,828
+25,594
| +13% | +$547K |
|
|
AKYA
129
DELISTED
Akoya BioSciences
AKYA
| $4.69M | 0.15% |
398,824
+292,482
| +275% | +$3.44M |
|
130
InMode
INMD
$911M
| $4.59M | 0.15% |
157,571
-45,008
| -22% | -$1.31M |
|
131
Biomerica
BMRA
$7.94M
| $4.4M | 0.14% |
139,961
+2,087
| +2% | +$65.6K |
|
132
Xencor
XNCR
$597M
| $4.37M | 0.14% |
168,307
-655
| -0.4% | -$17K |
|
133
Littelfuse
LFUS
$6.43B
| $4.27M | 0.14% |
21,491
+4,347
| +25% | +$864K |
|
|
HSKA
134
DELISTED
Heska Corp
HSKA
| $4.2M | 0.14% |
57,654
-5,999
| -9% | -$437K |
|
135
Silicon Laboratories
SLAB
$4.43B
| $4.13M | 0.13% |
33,475
+447
| +1% | +$55.2K |
|
136
Grocery Outlet
GO
$1.78B
| $4.09M | 0.13% |
122,858
+44,637
| +57% | +$1.49M |
|
137
Airgain
AIRG
$50.6M
| $4.01M | 0.13% |
555,677
+66,145
| +14% | +$477K |
|
138
CyberArk
CYBR
$23.1B
| $3.93M | 0.13% |
26,196
+4,825
| +23% | +$723K |
|
139
Kezar Life Sciences
KZR
$28M
| $3.85M | 0.13% |
44,742
+17,126
| +62% | +$1.47M |
|
140
Innovative Industrial Properties
IIPR
$1.59B
| $3.84M | 0.13% |
43,430
-35,604
| -45% | -$3.15M |
|
141
Harvard Bioscience
HBIO
$20.8M
| $3.82M | 0.12% |
1,493,269
-39,424
| -3% | -$101K |
|
|
BLUE
142
DELISTED
bluebird bio
BLUE
| $3.73M | 0.12% |
+29,454
| New | +$3.73M |
|
143
Zymeworks
ZYME
$1.07B
| $3.62M | 0.12% |
587,808
+239,987
| +69% | +$1.48M |
|
144
CRISPR Therapeutics
CRSP
$4.8B
| $3.4M | 0.11% |
52,006
+2,230
| +4% | +$146K |
|
145
Pacific Biosciences
PACB
$372M
| $3.33M | 0.11% |
574,189
-147,219
| -20% | -$855K |
|
146
Stoke Therapeutics
STOK
$1.08B
| $3.33M | 0.11% |
259,014
+60,393
| +30% | +$776K |
|
147
Monolithic Power Systems
MPWR
$40.6B
| $3.24M | 0.11% |
8,927
+799
| +10% | +$290K |
|
148
Appian
APPN
$2.22B
| $3.15M | 0.1% |
77,054
+1,438
| +2% | +$58.7K |
|
149
ThredUp
TDUP
$1.44B
| $3.08M | 0.1% |
1,676,193
+156,674
| +10% | +$288K |
|
150
Match Group
MTCH
$9B
| $3.06M | 0.1% |
64,130
+3,937
| +7% | +$188K |
|